Twenty Bone-mineral-density Loci Identified by Large-scale Meta-analysis of Genome-wide Association Studies

Bone mineral density (BMD) is a heritable complex trait used in the clinical diagnosis of osteoporosis and the assessment of fracture risk. We performed meta-analysis of five genome-wide association studies of femoral neck and lumbar spine BMD in 19,195 subjects of Northern European descent. We identified 20 BMD loci that reached genome-wide significance (GWS; P < 5 x 10(-8)), of which 13 map to regions not previously associated with this trait: 1p31.3 (GPR177), 2p21 (SPTBN1), 3p22 (CTNNB1), 4q21.1 (MEPE), 5q14 (MEF2C), 7p14 (STARD3NL), 7q21.3 (FLJ42280), 11p11.2 (LRP4, ARHGAP1, F2), 11p14.1 (DCDC5), 11p15 (SOX6), 16q24 (FOXL1), 17q21 (HDAC5) and 17q12 (CRHR1). The meta-analysis also confirmed at GWS level seven known BMD loci on 1p36 (ZBTB40), 6q25 (ESR1), 8q24 (TNFRSF11B), 11q13.4 (LRP5), 12q13 (SP7), 13q14 (TNFSF11) and 18q21 (TNFRSF11A). The many SNPs associated with BMD map to genes in signaling pathways with relevance to bone metabolism and highlight the complex genetic architecture that underlies osteoporosis and variation in BMD.

Citing Articles

[Development of prognostic clinical and genetic models of the risk of low bone mineral density using neural network training].

Yalaev B, Novikov A, Minniakhmetov I, Khusainova R Probl Endokrinol (Mosk). 2025; 70(6):67-82.

PMID: 39868449 PMC: 11775677. DOI: 10.14341/probl13421.

OGT mediated HDAC5 O-GlcNAcylation promotes osteogenesis by regulating the homeostasis of epigenetic modifications and proteolysis.

Du Y, Gao X, Chen J, Chen X, Liu H, He W J Orthop Translat. 2024; 50:14-29.

PMID: 39659899 PMC: 11626777. DOI: 10.1016/j.jot.2024.10.004.

Bone health in childhood cancer survivors, is there really a problem? Pitfalls of assessment, calculating risk, and suggested surveillance and management for osteonecrosis and low and very low bone mineral density.

de Winter D, Neggers S, van den Heuvel-Eibrink M, van Atteveld J Endocr Connect. 2024; 13(12).

PMID: 39437150 PMC: 11623254. DOI: 10.1530/EC-24-0487.

Exploring estrogen-related mechanisms in ovarian carcinogenesis: association between bone mineral density and ovarian cancer risk in a multivariable Mendelian randomization study.

Tuesley K, Webb P, Protani M, Donovan P, Jordan S, Dixon-Suen S Cancer Causes Control. 2024; 36(2):171-182.

PMID: 39419895 PMC: 11775049. DOI: 10.1007/s10552-024-01926-9.

MicroRNA binding site variants-new potential markers of primary osteoporosis in men and women.

Yalaev B, Deev R, Tyurin A, Salakhov R, Smirnov K, Eremkina A Front Genet. 2024; 15:1470310.

PMID: 39411371 PMC: 11473367. DOI: 10.3389/fgene.2024.1470310.

References

Weedon M, Lango H, Lindgren C, Wallace C, Evans D, Mangino M . Genome-wide association analysis identifies 20 loci that influence adult height. Nat Genet. 2008; 40(5):575-83. PMC: 2681221. DOI: 10.1038/ng.121. View

Theoleyre S, Wittrant Y, Tat S, Fortun Y, Redini F, Heymann D . The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling. Cytokine Growth Factor Rev. 2004; 15(6):457-75. DOI: 10.1016/j.cytogfr.2004.06.004. View

Arden N, Baker J, Hogg C, Baan K, Spector T . The heritability of bone mineral density, ultrasound of the calcaneus and hip axis length: a study of postmenopausal twins. J Bone Miner Res. 1996; 11(4):530-4. DOI: 10.1002/jbmr.5650110414. View

Ioannidis J, Thomas G, Daly M . Validating, augmenting and refining genome-wide association signals. Nat Rev Genet. 2009; 10(5):318-29. PMC: 7877552. DOI: 10.1038/nrg2544. View

Ioannidis J, Ralston S, Bennett S, Brandi M, Grinberg D, Karassa F . Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes. JAMA. 2004; 292(17):2105-14. DOI: 10.1001/jama.292.17.2105. View

Grundberg E, Brandstrom H, C L Lam K, Gurd S, Ge B, Harmsen E . Systematic assessment of the human osteoblast transcriptome in resting and induced primary cells. Physiol Genomics. 2008; 33(3):301-11. DOI: 10.1152/physiolgenomics.00028.2008. View

Schroeder T, Westendorf J . Histone deacetylase inhibitors promote osteoblast maturation. J Bone Miner Res. 2005; 20(12):2254-63. DOI: 10.1359/JBMR.050813. View

Kannel W, Feinleib M, MCNAMARA P, Garrison R, CASTELLI W . An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol. 1979; 110(3):281-90. DOI: 10.1093/oxfordjournals.aje.a112813. View

Alford A, Hankenson K . Matricellular proteins: Extracellular modulators of bone development, remodeling, and regeneration. Bone. 2006; 38(6):749-57. DOI: 10.1016/j.bone.2005.11.017. View

10.

Schuit S, van der Klift M, Weel A, de Laet C, Burger H, Seeman E . Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone. 2004; 34(1):195-202. DOI: 10.1016/j.bone.2003.10.001. View

11.

Smits P, Li P, Mandel J, Zhang Z, Deng J, Behringer R . The transcription factors L-Sox5 and Sox6 are essential for cartilage formation. Dev Cell. 2001; 1(2):277-90. DOI: 10.1016/s1534-5807(01)00003-x. View

12.

Winnier G, Hargett L, Hogan B . The winged helix transcription factor MFH1 is required for proliferation and patterning of paraxial mesoderm in the mouse embryo. Genes Dev. 1997; 11(7):926-40. DOI: 10.1101/gad.11.7.926. View

13.

DAWBER T, Kannel W, LYELL L . An approach to longitudinal studies in a community: the Framingham Study. Ann N Y Acad Sci. 1963; 107:539-56. DOI: 10.1111/j.1749-6632.1963.tb13299.x. View

14.

Tang Y, Katuri V, Dillner A, Mishra B, Deng C, Mishra L . Disruption of transforming growth factor-beta signaling in ELF beta-spectrin-deficient mice. Science. 2003; 299(5606):574-7. DOI: 10.1126/science.1075994. View

15.

Potthoff M, Wu H, Arnold M, Shelton J, Backs J, McAnally J . Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers. J Clin Invest. 2007; 117(9):2459-67. PMC: 1957540. DOI: 10.1172/JCI31960. View

16.

Ioannidis J . Why most published research findings are false. PLoS Med. 2005; 2(8):e124. PMC: 1182327. DOI: 10.1371/journal.pmed.0020124. View

17.

Kutyavin I, Milesi D, Belousov Y, Podyminogin M, Vorobiev A, Gorn V . A novel endonuclease IV post-PCR genotyping system. Nucleic Acids Res. 2006; 34(19):e128. PMC: 1636472. DOI: 10.1093/nar/gkl679. View

18.

Blake G, Knapp K, Spector T, Fogelman I . Predicting the risk of fracture at any site in the skeleton: are all bone mineral density measurement sites equally effective?. Calcif Tissue Int. 2005; 78(1):9-17. DOI: 10.1007/s00223-005-0127-3. View

19.

Styrkarsdottir U, Halldorsson B, Gretarsdottir S, Gudbjartsson D, Walters G, Ingvarsson T . New sequence variants associated with bone mineral density. Nat Genet. 2008; 41(1):15-7. DOI: 10.1038/ng.284. View

20.

Peer I, Yelensky R, Altshuler D, Daly M . Estimation of the multiple testing burden for genomewide association studies of nearly all common variants. Genet Epidemiol. 2008; 32(4):381-5. DOI: 10.1002/gepi.20303. View